Medios Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Medios wird ein jährliches Gewinn- und Umsatzwachstum von 41.4% bzw. 6.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 39.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 8.5% betragen.

Wichtige Informationen

40.9%

Wachstumsrate der Gewinne

38.5%

EPS-Wachstumsrate

Healthcare Gewinnwachstum	20.7%
Wachstumsrate der Einnahmen	5.8%
Zukünftige Eigenkapitalrendite	8.1%
Analystenabdeckung	Low
Zuletzt aktualisiert	21 Aug 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Medios (ETR:ILM1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

May 21

Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 17

Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts

Jan 21

What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition

Jan 19

Is It Time To Consider Buying Medios AG (ETR:ILM1)?

Dec 24

Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week

Dec 09

The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It

Dec 08

Medios AG's (ETR:ILM1) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 22

What Can We Make Of Medios AG’s (ETR:ILM1) High Return On Capital?

Jun 22

Gewinn- und Umsatzwachstumsprognosen

XTRA:ILM1 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	2,228	48	55	70	5
12/31/2025	2,139	43	47	61	5
12/31/2024	1,985	25	38	47	5
6/30/2024	1,838	16	123	126	N/A
3/31/2024	1,810	18	84	85	N/A
12/31/2023	1,785	19	15	16	N/A
9/30/2023	1,743	19	28	30	N/A
6/30/2023	1,673	18	-51	-48	N/A
3/31/2023	1,650	18	11	14	N/A
12/31/2022	1,612	18	32	37	N/A
9/30/2022	1,581	13	32	39	N/A
6/30/2022	1,516	11	32	42	N/A
3/31/2022	1,436	10	25	38	N/A
12/31/2021	1,359	7	49	62	N/A
9/30/2021	1,163	11	-15	-5	N/A
6/30/2021	969	9	-24	-15	N/A
3/31/2021	780	6	-12	-6	N/A
12/31/2020	627	6	-43	-38	N/A
9/30/2020	599	6	0	2	N/A
6/30/2020	582	9	2	5	N/A
3/31/2020	566	10	-14	-11	N/A
12/31/2019	518	10	-3	0	N/A
9/30/2019	464	9	0	3	N/A
6/30/2019	413	7	-3	-1	N/A
3/31/2019	371	6	-4	-2	N/A
12/31/2018	329	4	-5	-3	N/A
9/30/2018	305	4	-3	-1	N/A
6/30/2018	282	3	-2	2	N/A
3/31/2018	268	4	N/A	1	N/A
12/31/2017	254	4	N/A	1	N/A
9/30/2017	224	1	N/A	-2	N/A
6/30/2017	193	-2	N/A	-5	N/A
3/31/2017	163	-3	N/A	-3	N/A
12/31/2016	133	-3	N/A	-2	N/A
12/31/2015	58	1	N/A	1	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ILM1Das prognostizierte Gewinnwachstum (41.4% pro Jahr) liegt über der Sparquote (0.8%).

Ertrag vs. Markt: ILM1Die Erträge des Unternehmens (41.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (20% pro Jahr).

Hohe Wachstumserträge: ILM1Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: ILM1Die Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (5.1% pro Jahr).

Hohe Wachstumseinnahmen: ILM1Die Einnahmen des Unternehmens (6.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ILM1Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (8.1%).

Medios Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 15%

Price target decreased by 12% to €32.40

Price target decreased by 14% to €34.60

Price target decreased by 19% to €34.25

Price target decreased by 7.4% to €42.40

Consensus forecasts updated

Recent updates

Consensus EPS estimates fall by 15%

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

New minor risk - Shareholder dilution

Price target decreased by 12% to €32.40

Medios AG (XTRA:ILM1) acquired Ceban B.V. from Bencis Capital Partners B.V.

Medios (ETR:ILM1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

First quarter 2024 earnings released: EPS: €0.17 (vs €0.20 in 1Q 2023)

Price target decreased by 14% to €34.60

Full year 2023 earnings: EPS and revenues miss analyst expectations

Medios AG (XTRA:ILM1) agreed to acquire Ceban B.V. from Bencis Capital Partners B.V. for € 259 million.

Investor sentiment improves as stock rises 21%

Medios AG (XTRA:ILM1) agreed to acquire Ceban B.V. from Bencis Capital Partners B.V. for € 259 million.

Medios AG, Annual General Meeting, Jun 26, 2024

Medios AG to Report Q2, 2024 Results on Aug 13, 2024

Price target decreased by 19% to €34.25

Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Medios AG to Report Q3, 2023 Results on Nov 14, 2023

Second quarter 2023 earnings released: EPS: €0.19 (vs €0.21 in 2Q 2022)

First quarter 2023 earnings released: EPS: €0.20 (vs €0.21 in 1Q 2022)

Full year 2022 earnings released: EPS: €0.77 (vs €0.37 in FY 2021)

Price target decreased by 7.4% to €42.40

Is Medios AG (ETR:ILM1) Trading At A 39% Discount?

Medios AG to Report First Half, 2023 Results on Aug 14, 2023

Investor sentiment improved over the past week

Is Medios (ETR:ILM1) Using Too Much Debt?

Medios AG (XTRA:ILM1) entered into a purchase agreement to acquire Blisterzentrum Baden-Württemberg Gmbh.

Consensus forecasts updated

Third quarter 2022 earnings: EPS exceeds analyst expectations

Price target decreased to €45.80

Third quarter 2022 earnings: EPS exceeds analyst expectations

Is It Too Late To Consider Buying Medios AG (ETR:ILM1)?

Investor sentiment deteriorated over the past week

Here's Why Medios (ETR:ILM1) Can Manage Its Debt Responsibly

Is Now The Time To Look At Buying Medios AG (ETR:ILM1)?

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Is Medios (ETR:ILM1) Using Too Much Debt?

Consensus forecasts updated

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to €54.80

Investor sentiment deteriorated over the past week

Here's Why I Think Medios (ETR:ILM1) Is An Interesting Stock

What Does Medios AG's (ETR:ILM1) Share Price Indicate?

Medios AG Provides Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Medios (ETR:ILM1) Has A Pretty Healthy Balance Sheet

Medios AG (XTRA:ILM1) entered into an agreement to acquire NewCo Pharma GmbH.

Price target increased to €51.75

Third quarter 2021 earnings released: EPS €0.18 (vs €0.07 in 3Q 2020)

Is There Now An Opportunity In Medios AG (ETR:ILM1)?

Consensus forecasts updated

Second quarter 2021 earnings released: EPS €0.17 (vs €0.06 in 2Q 2020)

Medios AG's (ETR:ILM1) Intrinsic Value Is Potentially 35% Above Its Share Price

What Is Medios AG's (ETR:ILM1) Share Price Doing?

First quarter 2021 earnings released: EPS €0.15 (vs €0.15 in 1Q 2020)

Consensus forecasts updated

Full year 2020 earnings released: EPS €0.39 (vs €0.67 in FY 2019)

Medios AG Reiterates Revenue Guidance for the Financial Year 2021

New 90-day low: €34.80

Are Medios' (ETR:ILM1) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Medios AG (XTRA:ILM1) completed the acquisition of CRANACH PHARMA GmbH from BMSH GmbH.

Bullish: Analysts Just Made A Significant Upgrade To Their Medios AG (ETR:ILM1) Forecasts

What You Need To Know About Medios AG's (ETR:ILM1) Investor Composition

New 90-day high: €38.50

Is It Time To Consider Buying Medios AG (ETR:ILM1)?

Analysts Are Betting On Medios AG (ETR:ILM1) With A Big Upgrade This Week

The Medios (ETR:ILM1) Share Price Is Up 128% And Shareholders Are Boasting About It

Price target raised to €40.33

Medios AG to Report Q3, 2021 Results on Nov 09, 2021